Evolus, inc.EOLS.US Overview

US StockHealthcare

(No presentation for EOLS)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

EOLS Overall Performance

EOLS AI Analysis & Strategy

EOLS Recent Performance

1.14%

Evolus, inc.

0.81%

Avg of Sector

-1.14%

S&P500

EOLS PowerScanner

EOLS Key Information

EOLS Valuation Metrics

EOLS Earnings Table

EOLS Profile

Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.